1LLY:BIT
Eli Lilly And Co
1 017,40 €
arrow_downward
−0,57%(−5,80) 1 p
2. okt, 17:29:23 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 1LLY põhistatistika genereerimine…
Ava
1 023,60 €
Kõrge
1 031,00 €
Madal
1 016,00 €
Turu kapit.
1,08 trln
Keskm. maht
382,00
Maht
492,00
52 näd kõrgeim
1 106,80 €
52 näd madalaim
640,70 €
Töötajate arv
50 tuh
Ava
1 023,60 €
Kõrge
1 031,00 €
Madal
1 016,00 €
Turu kapit.
1,08 trln
Keskm. maht
382,00
Maht
492,00
52 näd kõrgeim
1 106,80 €
52 näd madalaim
640,70 €
Töötajate arv
50 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
1 tunni eest
Forget Zepbound: Eli Lilly's Next Weight-Loss Drug Could Be Its Biggest Blockbuster Yet
Longevity.Technology
·
1 tunni eest
Lilly and Novo share GLP-1 longevity data
Mugglehead Investment Magazine
·
3 tunni eest
Eli Lilly and Company gains FDA Jaypirca approval
The Motley Fool
·
5 tunni eest
Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
Profiil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Teave üksuse Eli Lilly And Co kohta
TegevjuhtDavid A. Ricks
Töötajad50 tuh
Asutatud1876
PeakontoridIndianapolis, Indiana, Ameerika Ühendriigid
Sektor-
Veebisaitlilly.com